OVERVIEW
The prevalence of gastroesophageal reflux disease (GERD) in the United States continues to increase, and up to half of patients with reflux symptoms do not get adequate relief from empiric therapy with proton pump inhibitors, the mainstay of GERD treatment. In this live, interactive townhall, expert faculty will discuss the latest evidence and data regarding the diagnosis and management of GERD and erosive esophagitis (EE), including new acid suppressive medications. Real-world patient cases will help learners contextualize clinical information on GERD evaluation and management to apply in their practices.
GOAL STATEMENT
The goal of this activity is for clinicians to be better able to assimilate data on new pharmacologic treatment approaches for erosive esophagitis (EE) and GERD into practice.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the: [LIST] [ITEM]Clinical data on acid-suppressive treatments for EE [ITEM]Characteristics of patients with EE who are appropriate candidates for pharmacologic treatments [/LIST] Have greater competence related to: [LIST] [ITEM]Selecting evidence-based treatments for patients with GERD and EE[/LIST] Demonstrate greater confidence in their ability to: [LIST] [ITEM]Implement new treatments for GERD and EE in practice [/LIST]
ACCREDITATION STATEMENT
[JALOGO] [MEDSCAPE] In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.5 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity For Nurses Awarded 1.50 contact hour(s) of nursing continuing professional development for RNs and APNs
Embassy Suites
Room : Capital A
900 10th Street NW
Washington, District of Columbia, 20001
This program is not affiliated with Digestive Disease Week®
Supported by an independent educational grant from Phathom Pharmaceuticals.